nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—epilepsy syndrome—migraine	0.28	1	CtDrD
Valproic Acid—Decreased Central Nervous System Disorganized Electrical Activity—Gabapentin—migraine	0.239	0.646	CiPCiCtD
Valproic Acid—Decreased Central Nervous System Disorganized Electrical Activity—Topiramate—migraine	0.131	0.354	CiPCiCtD
Valproic Acid—endogenous depression—Amitriptyline—migraine	0.0807	0.416	CpDpCtD
Valproic Acid—bipolar disorder—Topiramate—migraine	0.0719	0.371	CpDpCtD
Valproic Acid—bipolar disorder—Gabapentin—migraine	0.0413	0.213	CpDpCtD
Valproic Acid—CYP2C18—Verapamil—migraine	0.0151	0.151	CbGbCtD
Valproic Acid—SLC22A5—Verapamil—migraine	0.00966	0.0963	CbGbCtD
Valproic Acid—CYP2B6—Amitriptyline—migraine	0.00602	0.0601	CbGbCtD
Valproic Acid—CYP3A5—Propranolol—migraine	0.00549	0.0547	CbGbCtD
Valproic Acid—CYP2C19—Timolol—migraine	0.00497	0.0495	CbGbCtD
Valproic Acid—CYP2B6—Verapamil—migraine	0.00478	0.0477	CbGbCtD
Valproic Acid—CYP3A5—Amitriptyline—migraine	0.00475	0.0473	CbGbCtD
Valproic Acid—CYP2C8—Amitriptyline—migraine	0.00456	0.0455	CbGbCtD
Valproic Acid—CYP2C19—Propranolol—migraine	0.00443	0.0441	CbGbCtD
Valproic Acid—CYP1A2—Propranolol—migraine	0.00408	0.0407	CbGbCtD
Valproic Acid—CYP2C19—Amitriptyline—migraine	0.00383	0.0382	CbGbCtD
Valproic Acid—CYP3A5—Verapamil—migraine	0.00377	0.0376	CbGbCtD
Valproic Acid—CYP2C8—Verapamil—migraine	0.00362	0.0361	CbGbCtD
Valproic Acid—CYP1A2—Amitriptyline—migraine	0.00353	0.0352	CbGbCtD
Valproic Acid—CYP2C9—Amitriptyline—migraine	0.00318	0.0317	CbGbCtD
Valproic Acid—CYP2C19—Topiramate—migraine	0.00315	0.0314	CbGbCtD
Valproic Acid—CYP2C19—Verapamil—migraine	0.00304	0.0303	CbGbCtD
Valproic Acid—CYP1A2—Verapamil—migraine	0.0028	0.028	CbGbCtD
Valproic Acid—CYP2C9—Verapamil—migraine	0.00253	0.0252	CbGbCtD
Valproic Acid—CYP3A4—Propranolol—migraine	0.00214	0.0213	CbGbCtD
Valproic Acid—CYP3A4—Amitriptyline—migraine	0.00185	0.0185	CbGbCtD
Valproic Acid—CYP3A4—Topiramate—migraine	0.00152	0.0152	CbGbCtD
Valproic Acid—CYP3A4—Verapamil—migraine	0.00147	0.0146	CbGbCtD
Valproic Acid—HDAC2—Nortriptyline—Amitriptyline—migraine	0.000357	1	CbGdCrCtD
Valproic Acid—ACADSB—trigeminal ganglion—migraine	0.000299	0.0396	CbGeAlD
Valproic Acid—OGDH—cardiovascular system—migraine	0.000271	0.036	CbGeAlD
Valproic Acid—ALDH5A1—trigeminal ganglion—migraine	0.000263	0.0349	CbGeAlD
Valproic Acid—HDAC9—cardiovascular system—migraine	0.000239	0.0318	CbGeAlD
Valproic Acid—ALDH5A1—brainstem—migraine	0.000233	0.0309	CbGeAlD
Valproic Acid—ACADSB—cardiovascular system—migraine	0.000216	0.0286	CbGeAlD
Valproic Acid—ABAT—brainstem—migraine	0.000199	0.0264	CbGeAlD
Valproic Acid—UGT1A8—head—migraine	0.000198	0.0262	CbGeAlD
Valproic Acid—HDAC2—neck—migraine	0.000196	0.026	CbGeAlD
Valproic Acid—OGDH—head—migraine	0.000184	0.0244	CbGeAlD
Valproic Acid—OGDH—nervous system—migraine	0.000174	0.0231	CbGeAlD
Valproic Acid—HDAC2—trigeminal ganglion—migraine	0.000169	0.0225	CbGeAlD
Valproic Acid—OGDH—central nervous system—migraine	0.000168	0.0223	CbGeAlD
Valproic Acid—OGDH—cerebellum—migraine	0.000164	0.0218	CbGeAlD
Valproic Acid—HDAC9—head—migraine	0.000162	0.0215	CbGeAlD
Valproic Acid—HDAC9—nervous system—migraine	0.000154	0.0204	CbGeAlD
Valproic Acid—HDAC2—brainstem—migraine	0.00015	0.0199	CbGeAlD
Valproic Acid—ALDH5A1—Neuronal System—KCNK18—migraine	0.000149	0.043	CbGpPWpGaD
Valproic Acid—HDAC9—central nervous system—migraine	0.000148	0.0196	CbGeAlD
Valproic Acid—HDAC9—cerebellum—migraine	0.000145	0.0192	CbGeAlD
Valproic Acid—OGDH—brain—migraine	0.000133	0.0177	CbGeAlD
Valproic Acid—ACADSB—cerebellum—migraine	0.00013	0.0173	CbGeAlD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000129	0.0371	CbGpPWpGaD
Valproic Acid—ALDH5A1—head—migraine	0.000129	0.0171	CbGeAlD
Valproic Acid—HDAC2—cardiovascular system—migraine	0.000122	0.0162	CbGeAlD
Valproic Acid—ALDH5A1—nervous system—migraine	0.000122	0.0162	CbGeAlD
Valproic Acid—HDAC9—brain—migraine	0.000117	0.0156	CbGeAlD
Valproic Acid—ALDH5A1—central nervous system—migraine	0.000117	0.0156	CbGeAlD
Valproic Acid—ALDH5A1—cerebellum—migraine	0.000115	0.0152	CbGeAlD
Valproic Acid—SLC22A8—trigeminal ganglion—migraine	0.000114	0.0151	CbGeAlD
Valproic Acid—ABAT—Neuronal System—KCNK18—migraine	0.000113	0.0326	CbGpPWpGaD
Valproic Acid—ABAT—head—migraine	0.00011	0.0146	CbGeAlD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—HTR3A—migraine	0.00011	0.0315	CbGpPWpGaD
Valproic Acid—PTGS1—blood vessel—migraine	0.000109	0.0145	CbGeAlD
Valproic Acid—SLC16A1—cardiovascular system—migraine	0.000109	0.0144	CbGeAlD
Valproic Acid—ACADSB—brain—migraine	0.000106	0.014	CbGeAlD
Valproic Acid—ABAT—nervous system—migraine	0.000104	0.0138	CbGeAlD
Valproic Acid—ABAT—central nervous system—migraine	0.0001	0.0133	CbGeAlD
Valproic Acid—ABAT—cerebellum—migraine	9.81e-05	0.013	CbGeAlD
Valproic Acid—ALDH5A1—Transmission across Chemical Synapses—CACNA1A—migraine	9.52e-05	0.0274	CbGpPWpGaD
Valproic Acid—ALDH5A1—brain—migraine	9.32e-05	0.0124	CbGeAlD
Valproic Acid—SLC22A5—trigeminal ganglion—migraine	8.6e-05	0.0114	CbGeAlD
Valproic Acid—HDAC9—Signaling events mediated by HDAC Class II—ESR1—migraine	8.48e-05	0.0244	CbGpPWpGaD
Valproic Acid—HDAC2—head—migraine	8.28e-05	0.011	CbGeAlD
Valproic Acid—ABAT—brain—migraine	7.97e-05	0.0106	CbGeAlD
Valproic Acid—HDAC9—Neural Crest Differentiation—NOTCH4—migraine	7.94e-05	0.0229	CbGpPWpGaD
Valproic Acid—HDAC2—nervous system—migraine	7.85e-05	0.0104	CbGeAlD
Valproic Acid—HDAC2—central nervous system—migraine	7.56e-05	0.01	CbGeAlD
Valproic Acid—HDAC9—Signaling by NOTCH—NOTCH4—migraine	7.47e-05	0.0215	CbGpPWpGaD
Valproic Acid—HDAC2—cerebellum—migraine	7.39e-05	0.00981	CbGeAlD
Valproic Acid—SLC16A1—head—migraine	7.36e-05	0.00977	CbGeAlD
Valproic Acid—ALDH5A1—Neuronal System—CACNA1A—migraine	7.29e-05	0.021	CbGpPWpGaD
Valproic Acid—ABAT—Transmission across Chemical Synapses—CACNA1A—migraine	7.21e-05	0.0208	CbGpPWpGaD
Valproic Acid—SLC16A1—nervous system—migraine	6.98e-05	0.00926	CbGeAlD
Valproic Acid—SLC22A7—brain—migraine	6.98e-05	0.00926	CbGeAlD
Valproic Acid—HDAC9—Neural Crest Differentiation—NOTCH3—migraine	6.75e-05	0.0194	CbGpPWpGaD
Valproic Acid—SLC22A6—brain—migraine	6.74e-05	0.00894	CbGeAlD
Valproic Acid—SLC16A1—central nervous system—migraine	6.72e-05	0.00892	CbGeAlD
Valproic Acid—HDAC2—Notch Signaling Pathway—NOTCH4—migraine	6.58e-05	0.0189	CbGpPWpGaD
Valproic Acid—SLC16A1—cerebellum—migraine	6.57e-05	0.00872	CbGeAlD
Valproic Acid—CYP2A6—cerebellum—migraine	6.47e-05	0.00859	CbGeAlD
Valproic Acid—UGT1A6—Oxidative Stress—FOS—migraine	6.36e-05	0.0183	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling by NOTCH—NOTCH3—migraine	6.35e-05	0.0183	CbGpPWpGaD
Valproic Acid—HDAC2—brain—migraine	6e-05	0.00797	CbGeAlD
Valproic Acid—HDAC2—Notch Signaling Pathway—NOTCH3—migraine	5.59e-05	0.0161	CbGpPWpGaD
Valproic Acid—SLC22A8—head—migraine	5.56e-05	0.00738	CbGeAlD
Valproic Acid—ABAT—Neuronal System—CACNA1A—migraine	5.53e-05	0.0159	CbGpPWpGaD
Valproic Acid—CYP2B6—cardiovascular system—migraine	5.39e-05	0.00716	CbGeAlD
Valproic Acid—CYP2C9—cardiovascular system—migraine	5.34e-05	0.00709	CbGeAlD
Valproic Acid—SLC16A1—brain—migraine	5.33e-05	0.00708	CbGeAlD
Valproic Acid—SLC22A8—nervous system—migraine	5.28e-05	0.007	CbGeAlD
Valproic Acid—CYP2A6—brain—migraine	5.26e-05	0.00698	CbGeAlD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—HTR1A—migraine	5.21e-05	0.015	CbGpPWpGaD
Valproic Acid—HDAC2—Notch Signaling Pathway—NOTCH4—migraine	5.15e-05	0.0148	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—TAC1—migraine	5.13e-05	0.0148	CbGpPWpGaD
Valproic Acid—SLC22A8—central nervous system—migraine	5.08e-05	0.00674	CbGeAlD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—SLC6A4—migraine	5.03e-05	0.0145	CbGpPWpGaD
Valproic Acid—PTGS1—cardiovascular system—migraine	4.88e-05	0.00647	CbGeAlD
Valproic Acid—SLC22A7—Fluoropyrimidine Activity—MTHFR—migraine	4.68e-05	0.0135	CbGpPWpGaD
Valproic Acid—PTGS1—Prostaglandin Synthesis and Regulation—EDNRA—migraine	4.56e-05	0.0131	CbGpPWpGaD
Valproic Acid—HDAC2—Notch Signaling Pathway—NOTCH3—migraine	4.38e-05	0.0126	CbGpPWpGaD
Valproic Acid—SLC22A8—brain—migraine	4.03e-05	0.00535	CbGeAlD
Valproic Acid—SLC22A5—cerebellum—migraine	3.75e-05	0.00498	CbGeAlD
Valproic Acid—UGT1A6—NRF2 pathway—SLC6A4—migraine	3.65e-05	0.0105	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—BDNF—migraine	3.65e-05	0.0105	CbGpPWpGaD
Valproic Acid—CYP2B6—head—migraine	3.65e-05	0.00485	CbGeAlD
Valproic Acid—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	3.59e-05	0.0103	CbGpPWpGaD
Valproic Acid—Urinary tract disorder—Gabapentin—migraine	3.54e-05	0.000803	CcSEcCtD
Valproic Acid—Oedema peripheral—Gabapentin—migraine	3.54e-05	0.000801	CcSEcCtD
Valproic Acid—Dysuria—Topiramate—migraine	3.53e-05	0.000799	CcSEcCtD
Valproic Acid—Neutropenia—Topiramate—migraine	3.53e-05	0.000799	CcSEcCtD
Valproic Acid—Connective tissue disorder—Gabapentin—migraine	3.53e-05	0.000799	CcSEcCtD
Valproic Acid—Urethral disorder—Gabapentin—migraine	3.52e-05	0.000797	CcSEcCtD
Valproic Acid—Angiopathy—Timolol—migraine	3.5e-05	0.000792	CcSEcCtD
Valproic Acid—Pollakiuria—Topiramate—migraine	3.49e-05	0.000789	CcSEcCtD
Valproic Acid—Immune system disorder—Timolol—migraine	3.48e-05	0.000788	CcSEcCtD
Valproic Acid—Hypersensitivity—Propranolol—migraine	3.48e-05	0.000787	CcSEcCtD
Valproic Acid—Mediastinal disorder—Timolol—migraine	3.47e-05	0.000787	CcSEcCtD
Valproic Acid—CYP2B6—nervous system—migraine	3.46e-05	0.0046	CbGeAlD
Valproic Acid—Visual impairment—Gabapentin—migraine	3.46e-05	0.000783	CcSEcCtD
Valproic Acid—Urticaria—Verapamil—migraine	3.45e-05	0.00078	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Topiramate—migraine	3.44e-05	0.00078	CcSEcCtD
Valproic Acid—HDAC2—Neural Crest Differentiation—NOTCH4—migraine	3.44e-05	0.00991	CbGpPWpGaD
Valproic Acid—Arrhythmia—Timolol—migraine	3.44e-05	0.00078	CcSEcCtD
Valproic Acid—Nausea—Amitriptyline—migraine	3.44e-05	0.000779	CcSEcCtD
Valproic Acid—Weight increased—Topiramate—migraine	3.43e-05	0.000777	CcSEcCtD
Valproic Acid—Weight decreased—Topiramate—migraine	3.41e-05	0.000773	CcSEcCtD
Valproic Acid—Alopecia—Timolol—migraine	3.41e-05	0.000771	CcSEcCtD
Valproic Acid—Erythema multiforme—Gabapentin—migraine	3.39e-05	0.000769	CcSEcCtD
Valproic Acid—Asthenia—Propranolol—migraine	3.38e-05	0.000766	CcSEcCtD
Valproic Acid—Pneumonia—Topiramate—migraine	3.38e-05	0.000766	CcSEcCtD
Valproic Acid—Mental disorder—Timolol—migraine	3.38e-05	0.000765	CcSEcCtD
Valproic Acid—Malnutrition—Timolol—migraine	3.36e-05	0.00076	CcSEcCtD
Valproic Acid—Eye disorder—Gabapentin—migraine	3.35e-05	0.00076	CcSEcCtD
Valproic Acid—Depression—Topiramate—migraine	3.35e-05	0.00076	CcSEcCtD
Valproic Acid—Tinnitus—Gabapentin—migraine	3.35e-05	0.000758	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Topiramate—migraine	3.34e-05	0.000755	CcSEcCtD
Valproic Acid—CYP2B6—central nervous system—migraine	3.33e-05	0.00442	CbGeAlD
Valproic Acid—PTGS1—head—migraine	3.3e-05	0.00438	CbGeAlD
Valproic Acid—Tension—Timolol—migraine	3.29e-05	0.000746	CcSEcCtD
Valproic Acid—Dysgeusia—Timolol—migraine	3.29e-05	0.000744	CcSEcCtD
Valproic Acid—Stomatitis—Topiramate—migraine	3.28e-05	0.000742	CcSEcCtD
Valproic Acid—Conjunctivitis—Topiramate—migraine	3.27e-05	0.00074	CcSEcCtD
Valproic Acid—Urinary tract infection—Topiramate—migraine	3.27e-05	0.00074	CcSEcCtD
Valproic Acid—Nervousness—Timolol—migraine	3.26e-05	0.000738	CcSEcCtD
Valproic Acid—Immune system disorder—Gabapentin—migraine	3.24e-05	0.000734	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NOTCH—NOTCH4—migraine	3.24e-05	0.00932	CbGpPWpGaD
Valproic Acid—Mediastinal disorder—Gabapentin—migraine	3.24e-05	0.000733	CcSEcCtD
Valproic Acid—Diarrhoea—Propranolol—migraine	3.23e-05	0.000731	CcSEcCtD
Valproic Acid—Chills—Gabapentin—migraine	3.22e-05	0.000729	CcSEcCtD
Valproic Acid—Hypersensitivity—Verapamil—migraine	3.2e-05	0.000724	CcSEcCtD
Valproic Acid—Epistaxis—Topiramate—migraine	3.17e-05	0.000718	CcSEcCtD
Valproic Acid—Alopecia—Gabapentin—migraine	3.17e-05	0.000718	CcSEcCtD
Valproic Acid—Vision blurred—Timolol—migraine	3.16e-05	0.000716	CcSEcCtD
Valproic Acid—Sinusitis—Topiramate—migraine	3.16e-05	0.000715	CcSEcCtD
Valproic Acid—Mental disorder—Gabapentin—migraine	3.14e-05	0.000712	CcSEcCtD
Valproic Acid—Agranulocytosis—Topiramate—migraine	3.14e-05	0.000711	CcSEcCtD
Valproic Acid—PTGS1—nervous system—migraine	3.13e-05	0.00415	CbGeAlD
Valproic Acid—Malnutrition—Gabapentin—migraine	3.12e-05	0.000708	CcSEcCtD
Valproic Acid—Dizziness—Propranolol—migraine	3.12e-05	0.000706	CcSEcCtD
Valproic Acid—Asthenia—Verapamil—migraine	3.11e-05	0.000705	CcSEcCtD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—HTR2A—migraine	3.09e-05	0.00888	CbGpPWpGaD
Valproic Acid—Flatulence—Gabapentin—migraine	3.08e-05	0.000697	CcSEcCtD
Valproic Acid—Bradycardia—Topiramate—migraine	3.07e-05	0.000696	CcSEcCtD
Valproic Acid—Pruritus—Verapamil—migraine	3.07e-05	0.000695	CcSEcCtD
Valproic Acid—Tension—Gabapentin—migraine	3.07e-05	0.000694	CcSEcCtD
Valproic Acid—Angioedema—Timolol—migraine	3.07e-05	0.000694	CcSEcCtD
Valproic Acid—Dysgeusia—Gabapentin—migraine	3.06e-05	0.000693	CcSEcCtD
Valproic Acid—HDAC9—Cardiac Hypertrophic Response—TNF—migraine	3.06e-05	0.00879	CbGpPWpGaD
Valproic Acid—SLC22A5—brain—migraine	3.05e-05	0.00405	CbGeAlD
Valproic Acid—Haemoglobin—Topiramate—migraine	3.04e-05	0.000687	CcSEcCtD
Valproic Acid—Nervousness—Gabapentin—migraine	3.03e-05	0.000687	CcSEcCtD
Valproic Acid—Rhinitis—Topiramate—migraine	3.03e-05	0.000686	CcSEcCtD
Valproic Acid—Back pain—Gabapentin—migraine	3.02e-05	0.000684	CcSEcCtD
Valproic Acid—Haemorrhage—Topiramate—migraine	3.02e-05	0.000684	CcSEcCtD
Valproic Acid—Vertigo—Timolol—migraine	3.01e-05	0.000683	CcSEcCtD
Valproic Acid—PTGS1—central nervous system—migraine	3.01e-05	0.004	CbGeAlD
Valproic Acid—Hallucination—Topiramate—migraine	3e-05	0.00068	CcSEcCtD
Valproic Acid—Hypoaesthesia—Topiramate—migraine	3e-05	0.00068	CcSEcCtD
Valproic Acid—Muscle spasms—Gabapentin—migraine	3e-05	0.00068	CcSEcCtD
Valproic Acid—Vomiting—Propranolol—migraine	3e-05	0.000679	CcSEcCtD
Valproic Acid—Pharyngitis—Topiramate—migraine	3e-05	0.000679	CcSEcCtD
Valproic Acid—Urinary tract disorder—Topiramate—migraine	2.98e-05	0.000675	CcSEcCtD
Valproic Acid—Oedema peripheral—Topiramate—migraine	2.98e-05	0.000674	CcSEcCtD
Valproic Acid—Rash—Propranolol—migraine	2.97e-05	0.000673	CcSEcCtD
Valproic Acid—Dermatitis—Propranolol—migraine	2.97e-05	0.000673	CcSEcCtD
Valproic Acid—Diarrhoea—Verapamil—migraine	2.97e-05	0.000672	CcSEcCtD
Valproic Acid—Connective tissue disorder—Topiramate—migraine	2.97e-05	0.000672	CcSEcCtD
Valproic Acid—Palpitations—Timolol—migraine	2.97e-05	0.000671	CcSEcCtD
Valproic Acid—Urethral disorder—Topiramate—migraine	2.96e-05	0.00067	CcSEcCtD
Valproic Acid—CYP2C8—brain—migraine	2.95e-05	0.00392	CbGeAlD
Valproic Acid—Vision blurred—Gabapentin—migraine	2.94e-05	0.000667	CcSEcCtD
Valproic Acid—Cough—Timolol—migraine	2.93e-05	0.000663	CcSEcCtD
Valproic Acid—HDAC2—Neural Crest Differentiation—NOTCH3—migraine	2.93e-05	0.00843	CbGpPWpGaD
Valproic Acid—Tremor—Gabapentin—migraine	2.93e-05	0.000663	CcSEcCtD
Valproic Acid—CYP2C18—FOXA1 transcription factor network—ESR1—migraine	2.91e-05	0.00839	CbGpPWpGaD
Valproic Acid—Visual impairment—Topiramate—migraine	2.91e-05	0.000659	CcSEcCtD
Valproic Acid—Ill-defined disorder—Gabapentin—migraine	2.9e-05	0.000656	CcSEcCtD
Valproic Acid—Hypertension—Timolol—migraine	2.9e-05	0.000656	CcSEcCtD
Valproic Acid—Anaemia—Gabapentin—migraine	2.89e-05	0.000654	CcSEcCtD
Valproic Acid—Agitation—Gabapentin—migraine	2.87e-05	0.00065	CcSEcCtD
Valproic Acid—Dizziness—Verapamil—migraine	2.87e-05	0.00065	CcSEcCtD
Valproic Acid—Arthralgia—Timolol—migraine	2.86e-05	0.000647	CcSEcCtD
Valproic Acid—Chest pain—Timolol—migraine	2.86e-05	0.000647	CcSEcCtD
Valproic Acid—Myalgia—Timolol—migraine	2.86e-05	0.000647	CcSEcCtD
Valproic Acid—Erythema multiforme—Topiramate—migraine	2.86e-05	0.000647	CcSEcCtD
Valproic Acid—Angioedema—Gabapentin—migraine	2.86e-05	0.000647	CcSEcCtD
Valproic Acid—Anxiety—Timolol—migraine	2.85e-05	0.000645	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	2.84e-05	0.000642	CcSEcCtD
Valproic Acid—Discomfort—Timolol—migraine	2.82e-05	0.000639	CcSEcCtD
Valproic Acid—Eye disorder—Topiramate—migraine	2.82e-05	0.000639	CcSEcCtD
Valproic Acid—UGT1A4—NRF2 pathway—SLC6A4—migraine	2.82e-05	0.00812	CbGpPWpGaD
Valproic Acid—Malaise—Gabapentin—migraine	2.82e-05	0.000638	CcSEcCtD
Valproic Acid—Tinnitus—Topiramate—migraine	2.82e-05	0.000638	CcSEcCtD
Valproic Acid—Vertigo—Gabapentin—migraine	2.81e-05	0.000636	CcSEcCtD
Valproic Acid—Nausea—Propranolol—migraine	2.8e-05	0.000634	CcSEcCtD
Valproic Acid—Leukopenia—Gabapentin—migraine	2.8e-05	0.000633	CcSEcCtD
Valproic Acid—Dry mouth—Timolol—migraine	2.79e-05	0.000633	CcSEcCtD
Valproic Acid—Palpitations—Gabapentin—migraine	2.76e-05	0.000625	CcSEcCtD
Valproic Acid—Confusional state—Timolol—migraine	2.76e-05	0.000625	CcSEcCtD
Valproic Acid—Vomiting—Verapamil—migraine	2.76e-05	0.000625	CcSEcCtD
Valproic Acid—UGT1A6—NRF2 pathway—TGFBR2—migraine	2.76e-05	0.00793	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—NOTCH3—migraine	2.75e-05	0.00793	CbGpPWpGaD
Valproic Acid—Angiopathy—Topiramate—migraine	2.74e-05	0.00062	CcSEcCtD
Valproic Acid—Oedema—Timolol—migraine	2.74e-05	0.00062	CcSEcCtD
Valproic Acid—Anaphylactic shock—Timolol—migraine	2.74e-05	0.00062	CcSEcCtD
Valproic Acid—Rash—Verapamil—migraine	2.74e-05	0.000619	CcSEcCtD
Valproic Acid—Dermatitis—Verapamil—migraine	2.73e-05	0.000619	CcSEcCtD
Valproic Acid—Immune system disorder—Topiramate—migraine	2.73e-05	0.000618	CcSEcCtD
Valproic Acid—Cough—Gabapentin—migraine	2.73e-05	0.000617	CcSEcCtD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—TRPM8—migraine	2.72e-05	0.00783	CbGpPWpGaD
Valproic Acid—Mediastinal disorder—Topiramate—migraine	2.72e-05	0.000616	CcSEcCtD
Valproic Acid—Infection—Timolol—migraine	2.72e-05	0.000616	CcSEcCtD
Valproic Acid—Headache—Verapamil—migraine	2.72e-05	0.000615	CcSEcCtD
Valproic Acid—Chills—Topiramate—migraine	2.71e-05	0.000614	CcSEcCtD
Valproic Acid—Hypertension—Gabapentin—migraine	2.7e-05	0.000611	CcSEcCtD
Valproic Acid—Nervous system disorder—Timolol—migraine	2.69e-05	0.000608	CcSEcCtD
Valproic Acid—Alopecia—Topiramate—migraine	2.67e-05	0.000604	CcSEcCtD
Valproic Acid—Chest pain—Gabapentin—migraine	2.66e-05	0.000602	CcSEcCtD
Valproic Acid—Myalgia—Gabapentin—migraine	2.66e-05	0.000602	CcSEcCtD
Valproic Acid—Arthralgia—Gabapentin—migraine	2.66e-05	0.000602	CcSEcCtD
Valproic Acid—Skin disorder—Timolol—migraine	2.66e-05	0.000602	CcSEcCtD
Valproic Acid—Anxiety—Gabapentin—migraine	2.65e-05	0.0006	CcSEcCtD
Valproic Acid—ACADSB—Metabolism—CACNA1A—migraine	2.65e-05	0.00762	CbGpPWpGaD
Valproic Acid—Hyperhidrosis—Timolol—migraine	2.65e-05	0.000599	CcSEcCtD
Valproic Acid—CYP2B6—brain—migraine	2.65e-05	0.00351	CbGeAlD
Valproic Acid—Mental disorder—Topiramate—migraine	2.65e-05	0.000599	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	2.64e-05	0.000598	CcSEcCtD
Valproic Acid—Malnutrition—Topiramate—migraine	2.63e-05	0.000595	CcSEcCtD
Valproic Acid—Discomfort—Gabapentin—migraine	2.63e-05	0.000595	CcSEcCtD
Valproic Acid—CYP2C18—FOXA1 transcription factor network—FOS—migraine	2.63e-05	0.00756	CbGpPWpGaD
Valproic Acid—CYP3A4—nervous system—migraine	2.61e-05	0.00347	CbGeAlD
Valproic Acid—Anorexia—Timolol—migraine	2.61e-05	0.000591	CcSEcCtD
Valproic Acid—Dry mouth—Gabapentin—migraine	2.6e-05	0.000589	CcSEcCtD
Valproic Acid—Flatulence—Topiramate—migraine	2.59e-05	0.000587	CcSEcCtD
Valproic Acid—Tension—Topiramate—migraine	2.58e-05	0.000584	CcSEcCtD
Valproic Acid—Nausea—Verapamil—migraine	2.58e-05	0.000584	CcSEcCtD
Valproic Acid—Dysgeusia—Topiramate—migraine	2.57e-05	0.000583	CcSEcCtD
Valproic Acid—Confusional state—Gabapentin—migraine	2.57e-05	0.000582	CcSEcCtD
Valproic Acid—Hypotension—Timolol—migraine	2.56e-05	0.000579	CcSEcCtD
Valproic Acid—Nervousness—Topiramate—migraine	2.55e-05	0.000578	CcSEcCtD
Valproic Acid—Oedema—Gabapentin—migraine	2.55e-05	0.000577	CcSEcCtD
Valproic Acid—Anaphylactic shock—Gabapentin—migraine	2.55e-05	0.000577	CcSEcCtD
Valproic Acid—Back pain—Topiramate—migraine	2.54e-05	0.000576	CcSEcCtD
Valproic Acid—Infection—Gabapentin—migraine	2.53e-05	0.000574	CcSEcCtD
Valproic Acid—Muscle spasms—Topiramate—migraine	2.53e-05	0.000572	CcSEcCtD
Valproic Acid—HDAC9—Signaling events mediated by HDAC Class I—TNF—migraine	2.52e-05	0.00725	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—TRPM8—migraine	2.52e-05	0.00725	CbGpPWpGaD
Valproic Acid—CYP3A4—central nervous system—migraine	2.52e-05	0.00334	CbGeAlD
Valproic Acid—CYP2A6—Fluoropyrimidine Activity—MTHFR—migraine	2.51e-05	0.00724	CbGpPWpGaD
Valproic Acid—Nervous system disorder—Gabapentin—migraine	2.5e-05	0.000566	CcSEcCtD
Valproic Acid—Thrombocytopenia—Gabapentin—migraine	2.5e-05	0.000565	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Timolol—migraine	2.5e-05	0.000565	CcSEcCtD
Valproic Acid—Tachycardia—Gabapentin—migraine	2.49e-05	0.000564	CcSEcCtD
Valproic Acid—Vision blurred—Topiramate—migraine	2.48e-05	0.000561	CcSEcCtD
Valproic Acid—Skin disorder—Gabapentin—migraine	2.48e-05	0.000561	CcSEcCtD
Valproic Acid—Insomnia—Timolol—migraine	2.48e-05	0.000561	CcSEcCtD
Valproic Acid—Hyperhidrosis—Gabapentin—migraine	2.47e-05	0.000558	CcSEcCtD
Valproic Acid—Tremor—Topiramate—migraine	2.46e-05	0.000558	CcSEcCtD
Valproic Acid—Paraesthesia—Timolol—migraine	2.46e-05	0.000557	CcSEcCtD
Valproic Acid—Dyspnoea—Timolol—migraine	2.44e-05	0.000553	CcSEcCtD
Valproic Acid—Ill-defined disorder—Topiramate—migraine	2.44e-05	0.000552	CcSEcCtD
Valproic Acid—Somnolence—Timolol—migraine	2.43e-05	0.000551	CcSEcCtD
Valproic Acid—Anorexia—Gabapentin—migraine	2.43e-05	0.00055	CcSEcCtD
Valproic Acid—Anaemia—Topiramate—migraine	2.43e-05	0.00055	CcSEcCtD
Valproic Acid—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	2.43e-05	0.00699	CbGpPWpGaD
Valproic Acid—Agitation—Topiramate—migraine	2.42e-05	0.000547	CcSEcCtD
Valproic Acid—Dyspepsia—Timolol—migraine	2.41e-05	0.000546	CcSEcCtD
Valproic Acid—PTGS1—brain—migraine	2.39e-05	0.00318	CbGeAlD
Valproic Acid—Hypotension—Gabapentin—migraine	2.38e-05	0.00054	CcSEcCtD
Valproic Acid—Decreased appetite—Timolol—migraine	2.38e-05	0.000539	CcSEcCtD
Valproic Acid—Malaise—Topiramate—migraine	2.37e-05	0.000537	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Timolol—migraine	2.36e-05	0.000535	CcSEcCtD
Valproic Acid—Vertigo—Topiramate—migraine	2.36e-05	0.000535	CcSEcCtD
Valproic Acid—Fatigue—Timolol—migraine	2.36e-05	0.000535	CcSEcCtD
Valproic Acid—Leukopenia—Topiramate—migraine	2.35e-05	0.000533	CcSEcCtD
Valproic Acid—UGT1A3—NRF2 pathway—SLC6A4—migraine	2.35e-05	0.00675	CbGpPWpGaD
Valproic Acid—Pain—Timolol—migraine	2.34e-05	0.00053	CcSEcCtD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—TRPM8—migraine	2.34e-05	0.00674	CbGpPWpGaD
Valproic Acid—Musculoskeletal discomfort—Gabapentin—migraine	2.32e-05	0.000526	CcSEcCtD
Valproic Acid—Palpitations—Topiramate—migraine	2.32e-05	0.000526	CcSEcCtD
Valproic Acid—HDAC2—Regulation of Telomerase—ESR1—migraine	2.31e-05	0.00664	CbGpPWpGaD
Valproic Acid—Insomnia—Gabapentin—migraine	2.31e-05	0.000522	CcSEcCtD
Valproic Acid—Cough—Topiramate—migraine	2.29e-05	0.000519	CcSEcCtD
Valproic Acid—Paraesthesia—Gabapentin—migraine	2.29e-05	0.000519	CcSEcCtD
Valproic Acid—Dyspnoea—Gabapentin—migraine	2.27e-05	0.000515	CcSEcCtD
Valproic Acid—Hypertension—Topiramate—migraine	2.27e-05	0.000514	CcSEcCtD
Valproic Acid—Somnolence—Gabapentin—migraine	2.27e-05	0.000513	CcSEcCtD
Valproic Acid—Feeling abnormal—Timolol—migraine	2.26e-05	0.000511	CcSEcCtD
Valproic Acid—OGDH—Metabolism—CACNA1A—migraine	2.25e-05	0.00648	CbGpPWpGaD
Valproic Acid—Dyspepsia—Gabapentin—migraine	2.24e-05	0.000508	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Timolol—migraine	2.24e-05	0.000507	CcSEcCtD
Valproic Acid—Myalgia—Topiramate—migraine	2.24e-05	0.000507	CcSEcCtD
Valproic Acid—Arthralgia—Topiramate—migraine	2.24e-05	0.000507	CcSEcCtD
Valproic Acid—Chest pain—Topiramate—migraine	2.24e-05	0.000507	CcSEcCtD
Valproic Acid—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	2.24e-05	0.00644	CbGpPWpGaD
Valproic Acid—Anxiety—Topiramate—migraine	2.23e-05	0.000505	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	2.22e-05	0.000503	CcSEcCtD
Valproic Acid—Decreased appetite—Gabapentin—migraine	2.22e-05	0.000502	CcSEcCtD
Valproic Acid—Discomfort—Topiramate—migraine	2.21e-05	0.000501	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Gabapentin—migraine	2.2e-05	0.000499	CcSEcCtD
Valproic Acid—Fatigue—Gabapentin—migraine	2.2e-05	0.000498	CcSEcCtD
Valproic Acid—Dry mouth—Topiramate—migraine	2.19e-05	0.000496	CcSEcCtD
Valproic Acid—Pain—Gabapentin—migraine	2.18e-05	0.000494	CcSEcCtD
Valproic Acid—Constipation—Gabapentin—migraine	2.18e-05	0.000494	CcSEcCtD
Valproic Acid—HDAC9—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	2.18e-05	0.00627	CbGpPWpGaD
Valproic Acid—Urticaria—Timolol—migraine	2.18e-05	0.000493	CcSEcCtD
Valproic Acid—Abdominal pain—Timolol—migraine	2.16e-05	0.00049	CcSEcCtD
Valproic Acid—Body temperature increased—Timolol—migraine	2.16e-05	0.00049	CcSEcCtD
Valproic Acid—Confusional state—Topiramate—migraine	2.16e-05	0.00049	CcSEcCtD
Valproic Acid—Oedema—Topiramate—migraine	2.15e-05	0.000486	CcSEcCtD
Valproic Acid—Infection—Topiramate—migraine	2.13e-05	0.000483	CcSEcCtD
Valproic Acid—UGT1A4—NRF2 pathway—TGFBR2—migraine	2.13e-05	0.00613	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—TRPM8—migraine	2.12e-05	0.00609	CbGpPWpGaD
Valproic Acid—Nervous system disorder—Topiramate—migraine	2.1e-05	0.000476	CcSEcCtD
Valproic Acid—Feeling abnormal—Gabapentin—migraine	2.1e-05	0.000476	CcSEcCtD
Valproic Acid—Thrombocytopenia—Topiramate—migraine	2.1e-05	0.000476	CcSEcCtD
Valproic Acid—Tachycardia—Topiramate—migraine	2.09e-05	0.000474	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Gabapentin—migraine	2.09e-05	0.000472	CcSEcCtD
Valproic Acid—Skin disorder—Topiramate—migraine	2.08e-05	0.000472	CcSEcCtD
Valproic Acid—HDAC2—Regulation of Telomerase—FOS—migraine	2.08e-05	0.00599	CbGpPWpGaD
Valproic Acid—Hyperhidrosis—Topiramate—migraine	2.07e-05	0.00047	CcSEcCtD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—ATP1A3—migraine	2.06e-05	0.00594	CbGpPWpGaD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—ATP1A2—migraine	2.06e-05	0.00594	CbGpPWpGaD
Valproic Acid—Anorexia—Topiramate—migraine	2.05e-05	0.000463	CcSEcCtD
Valproic Acid—Urticaria—Gabapentin—migraine	2.03e-05	0.000459	CcSEcCtD
Valproic Acid—Hypersensitivity—Timolol—migraine	2.02e-05	0.000457	CcSEcCtD
Valproic Acid—Body temperature increased—Gabapentin—migraine	2.02e-05	0.000456	CcSEcCtD
Valproic Acid—Abdominal pain—Gabapentin—migraine	2.02e-05	0.000456	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	2.01e-05	0.00577	CbGpPWpGaD
Valproic Acid—Hypotension—Topiramate—migraine	2e-05	0.000454	CcSEcCtD
Valproic Acid—UGT2B7—NRF2 pathway—SLC6A4—migraine	1.99e-05	0.00574	CbGpPWpGaD
Valproic Acid—Asthenia—Timolol—migraine	1.96e-05	0.000445	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Topiramate—migraine	1.95e-05	0.000443	CcSEcCtD
Valproic Acid—Insomnia—Topiramate—migraine	1.94e-05	0.000439	CcSEcCtD
Valproic Acid—Pruritus—Timolol—migraine	1.94e-05	0.000439	CcSEcCtD
Valproic Acid—Paraesthesia—Topiramate—migraine	1.93e-05	0.000436	CcSEcCtD
Valproic Acid—Dyspnoea—Topiramate—migraine	1.91e-05	0.000433	CcSEcCtD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ATP1A3—migraine	1.91e-05	0.00549	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—ATP1A2—migraine	1.91e-05	0.00549	CbGpPWpGaD
Valproic Acid—Somnolence—Topiramate—migraine	1.91e-05	0.000432	CcSEcCtD
Valproic Acid—Dyspepsia—Topiramate—migraine	1.89e-05	0.000428	CcSEcCtD
Valproic Acid—Hypersensitivity—Gabapentin—migraine	1.88e-05	0.000425	CcSEcCtD
Valproic Acid—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.88e-05	0.0054	CbGpPWpGaD
Valproic Acid—Diarrhoea—Timolol—migraine	1.87e-05	0.000424	CcSEcCtD
Valproic Acid—Decreased appetite—Topiramate—migraine	1.87e-05	0.000422	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Topiramate—migraine	1.85e-05	0.000419	CcSEcCtD
Valproic Acid—Fatigue—Topiramate—migraine	1.85e-05	0.000419	CcSEcCtD
Valproic Acid—Constipation—Topiramate—migraine	1.83e-05	0.000415	CcSEcCtD
Valproic Acid—Pain—Topiramate—migraine	1.83e-05	0.000415	CcSEcCtD
Valproic Acid—Asthenia—Gabapentin—migraine	1.83e-05	0.000414	CcSEcCtD
Valproic Acid—HDAC2—Circadian rythm related genes—NPS—migraine	1.82e-05	0.00523	CbGpPWpGaD
Valproic Acid—Dizziness—Timolol—migraine	1.81e-05	0.00041	CcSEcCtD
Valproic Acid—HDAC2—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	1.81e-05	0.0052	CbGpPWpGaD
Valproic Acid—Pruritus—Gabapentin—migraine	1.8e-05	0.000409	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—FOS—migraine	1.79e-05	0.00515	CbGpPWpGaD
Valproic Acid—PTGS1—Overview of nanoparticle effects—TNF—migraine	1.78e-05	0.00513	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—SLC6A4—migraine	1.78e-05	0.00513	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ATP1A2—migraine	1.77e-05	0.00511	CbGpPWpGaD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—ATP1A3—migraine	1.77e-05	0.00511	CbGpPWpGaD
Valproic Acid—UGT1A3—NRF2 pathway—TGFBR2—migraine	1.77e-05	0.00509	CbGpPWpGaD
Valproic Acid—Feeling abnormal—Topiramate—migraine	1.77e-05	0.0004	CcSEcCtD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—TRPM8—migraine	1.77e-05	0.00509	CbGpPWpGaD
Valproic Acid—Gastrointestinal pain—Topiramate—migraine	1.75e-05	0.000397	CcSEcCtD
Valproic Acid—SLC16A1—Transmembrane transport of small molecules—HTR3A—migraine	1.75e-05	0.00505	CbGpPWpGaD
Valproic Acid—Diarrhoea—Gabapentin—migraine	1.74e-05	0.000395	CcSEcCtD
Valproic Acid—Vomiting—Timolol—migraine	1.74e-05	0.000394	CcSEcCtD
Valproic Acid—Rash—Timolol—migraine	1.73e-05	0.000391	CcSEcCtD
Valproic Acid—Dermatitis—Timolol—migraine	1.73e-05	0.000391	CcSEcCtD
Valproic Acid—Headache—Timolol—migraine	1.72e-05	0.000388	CcSEcCtD
Valproic Acid—Urticaria—Topiramate—migraine	1.7e-05	0.000386	CcSEcCtD
Valproic Acid—Body temperature increased—Topiramate—migraine	1.7e-05	0.000384	CcSEcCtD
Valproic Acid—Abdominal pain—Topiramate—migraine	1.7e-05	0.000384	CcSEcCtD
Valproic Acid—Dizziness—Gabapentin—migraine	1.69e-05	0.000382	CcSEcCtD
Valproic Acid—Nausea—Timolol—migraine	1.63e-05	0.000368	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—CALCRL—migraine	1.63e-05	0.00468	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—RAMP1—migraine	1.63e-05	0.00468	CbGpPWpGaD
Valproic Acid—SLC22A7—Transmembrane transport of small molecules—HTR3A—migraine	1.62e-05	0.00467	CbGpPWpGaD
Valproic Acid—Vomiting—Gabapentin—migraine	1.62e-05	0.000367	CcSEcCtD
Valproic Acid—UGT1A9—NRF2 pathway—SLC6A4—migraine	1.62e-05	0.00466	CbGpPWpGaD
Valproic Acid—Rash—Gabapentin—migraine	1.61e-05	0.000364	CcSEcCtD
Valproic Acid—Dermatitis—Gabapentin—migraine	1.61e-05	0.000364	CcSEcCtD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ATP1A2—migraine	1.6e-05	0.00462	CbGpPWpGaD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—ATP1A3—migraine	1.6e-05	0.00462	CbGpPWpGaD
Valproic Acid—Headache—Gabapentin—migraine	1.6e-05	0.000362	CcSEcCtD
Valproic Acid—Hypersensitivity—Topiramate—migraine	1.58e-05	0.000358	CcSEcCtD
Valproic Acid—HDAC2—Circadian rythm related genes—HTR7—migraine	1.56e-05	0.00449	CbGpPWpGaD
Valproic Acid—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.56e-05	0.00449	CbGpPWpGaD
Valproic Acid—Asthenia—Topiramate—migraine	1.54e-05	0.000349	CcSEcCtD
Valproic Acid—Pruritus—Topiramate—migraine	1.52e-05	0.000344	CcSEcCtD
Valproic Acid—Nausea—Gabapentin—migraine	1.51e-05	0.000343	CcSEcCtD
Valproic Acid—SLC22A5—Transmembrane transport of small molecules—HTR3A—migraine	1.51e-05	0.00434	CbGpPWpGaD
Valproic Acid—UGT2B7—NRF2 pathway—TGFBR2—migraine	1.5e-05	0.00433	CbGpPWpGaD
Valproic Acid—Diarrhoea—Topiramate—migraine	1.47e-05	0.000332	CcSEcCtD
Valproic Acid—Dizziness—Topiramate—migraine	1.42e-05	0.000321	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—CACNA1A—migraine	1.39e-05	0.004	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—LRP1—migraine	1.38e-05	0.00397	CbGpPWpGaD
Valproic Acid—Vomiting—Topiramate—migraine	1.36e-05	0.000309	CcSEcCtD
Valproic Acid—SLC22A8—Transmembrane transport of small molecules—HTR3A—migraine	1.36e-05	0.00393	CbGpPWpGaD
Valproic Acid—Rash—Topiramate—migraine	1.35e-05	0.000306	CcSEcCtD
Valproic Acid—Dermatitis—Topiramate—migraine	1.35e-05	0.000306	CcSEcCtD
Valproic Acid—Headache—Topiramate—migraine	1.34e-05	0.000304	CcSEcCtD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ATP1A2—migraine	1.34e-05	0.00385	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—ATP1A3—migraine	1.34e-05	0.00385	CbGpPWpGaD
Valproic Acid—HDAC9—SIDS Susceptibility Pathways—TNF—migraine	1.33e-05	0.00382	CbGpPWpGaD
Valproic Acid—Nausea—Topiramate—migraine	1.27e-05	0.000289	CcSEcCtD
Valproic Acid—CYP2A6—NRF2 pathway—SLC6A4—migraine	1.25e-05	0.0036	CbGpPWpGaD
Valproic Acid—UGT1A9—NRF2 pathway—TGFBR2—migraine	1.22e-05	0.00352	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CACNA1A—migraine	1.22e-05	0.0035	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—MTHFR—migraine	1.21e-05	0.00349	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HTR1D—migraine	1.18e-05	0.0034	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—HTR3A—migraine	1.14e-05	0.00328	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HTR2B—migraine	1.1e-05	0.00316	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling events mediated by HDAC Class I—TNF—migraine	1.09e-05	0.00314	CbGpPWpGaD
Valproic Acid—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.08e-05	0.0031	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CACNA1A—migraine	1.02e-05	0.00292	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—LRP1—migraine	9.67e-06	0.00278	CbGpPWpGaD
Valproic Acid—CYP2A6—NRF2 pathway—TGFBR2—migraine	9.42e-06	0.00271	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—CALCA—migraine	8.9e-06	0.00256	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—MTHFR—migraine	8.76e-06	0.00252	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	8.14e-06	0.00234	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CACNA1A—migraine	7.84e-06	0.00226	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—MTHFR—migraine	7.45e-06	0.00214	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NOTCH4—migraine	7.42e-06	0.00213	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFBR2—migraine	7.17e-06	0.00206	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HTR1B—migraine	7.16e-06	0.00206	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RAMP1—migraine	7.05e-06	0.00203	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CALCRL—migraine	7.05e-06	0.00203	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CACNA1A—migraine	6.99e-06	0.00201	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HTR1A—migraine	6.89e-06	0.00198	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—PGR—migraine	6.78e-06	0.00195	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TAC1—migraine	6.78e-06	0.00195	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NPS—migraine	6.78e-06	0.00195	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HTR2C—migraine	6.65e-06	0.00191	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CACNA1A—migraine	6.52e-06	0.00188	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EDNRA—migraine	6.47e-06	0.00186	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—NOTCH3—migraine	6.31e-06	0.00182	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—CALCA—migraine	6.23e-06	0.00179	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—LRP1—migraine	5.99e-06	0.00172	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HTR7—migraine	5.83e-06	0.00168	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MTHFR—migraine	5.82e-06	0.00168	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CACNA1A—migraine	5.69e-06	0.00164	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CACNA1A—migraine	5.54e-06	0.00159	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—TNF—migraine	5.23e-06	0.0015	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR1D—migraine	5.12e-06	0.00147	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFBR2—migraine	5.02e-06	0.00144	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—NOTCH4—migraine	4.95e-06	0.00142	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR2B—migraine	4.76e-06	0.00137	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—MTHFR—migraine	4.6e-06	0.00132	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—PGR—migraine	4.52e-06	0.0013	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CACNA1A—migraine	4.5e-06	0.0013	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—NOTCH3—migraine	4.21e-06	0.00121	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—LRP1—migraine	4.19e-06	0.00121	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—HTR2A—migraine	4.08e-06	0.00117	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—MTHFR—migraine	4.02e-06	0.00116	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	3.94e-06	0.00114	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	3.94e-06	0.00114	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—CALCA—migraine	3.86e-06	0.00111	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CACNA1A—migraine	3.67e-06	0.00106	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ESR1—migraine	3.62e-06	0.00104	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CACNA1A—migraine	3.47e-06	0.000999	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—MTHFR—migraine	3.36e-06	0.000966	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NOTCH4—migraine	3.22e-06	0.000926	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFBR2—migraine	3.11e-06	0.000894	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR1B—migraine	3.1e-06	0.000893	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR1A—migraine	2.99e-06	0.00086	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TAC1—migraine	2.94e-06	0.000847	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NPS—migraine	2.94e-06	0.000847	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—PGR—migraine	2.94e-06	0.000847	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR2C—migraine	2.89e-06	0.00083	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EDNRA—migraine	2.81e-06	0.000808	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CACNA1A—migraine	2.8e-06	0.000806	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CACNA1A—migraine	2.74e-06	0.000788	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NOTCH3—migraine	2.73e-06	0.000787	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CALCA—migraine	2.7e-06	0.000778	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—MTHFR—migraine	2.59e-06	0.000746	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR7—migraine	2.53e-06	0.000727	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MTHFR—migraine	2.52e-06	0.000726	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—ESR1—migraine	2.42e-06	0.000695	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CACNA1A—migraine	2.37e-06	0.000682	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—MTHFR—migraine	2.31e-06	0.000665	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFBR2—migraine	2.18e-06	0.000626	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—MTHFR—migraine	2.16e-06	0.00062	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CACNA1A—migraine	2.12e-06	0.000609	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CACNA1A—migraine	1.93e-06	0.000555	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—MTHFR—migraine	1.88e-06	0.000542	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—MTHFR—migraine	1.83e-06	0.000527	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—HTR2A—migraine	1.77e-06	0.000509	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CACNA1A—migraine	1.65e-06	0.000474	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ESR1—migraine	1.57e-06	0.000452	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—MTHFR—migraine	1.49e-06	0.000429	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CACNA1A—migraine	1.27e-06	0.000366	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—MTHFR—migraine	1.21e-06	0.000349	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—MTHFR—migraine	1.15e-06	0.00033	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MTHFR—migraine	9.26e-07	0.000267	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MTHFR—migraine	9.05e-07	0.000261	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MTHFR—migraine	7.84e-07	0.000226	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MTHFR—migraine	7e-07	0.000201	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MTHFR—migraine	6.38e-07	0.000184	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTHFR—migraine	5.45e-07	0.000157	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTHFR—migraine	4.21e-07	0.000121	CbGpPWpGaD
